Riverlane and Astex Pharmaceuticals Join Forces with Rigetti Computing to Use Quantum for Drug Discovery

  PRESS RELEASE: Riverlane is leading a consortium with Rigetti Computing, alongside existing partners Astex Pharmaceuticals, to advance quantum computing for drug discovery. The trio will develop an integrated application for simulating molecular systems using Rigetti Quantum Cloud Services, paving the way for a commercial application that could transform drug discovery in pharmaceutical R&D. “Quantum computers provide a fundamentally different approach that could enable pharmaceutical companies to identify, screen, and simulate new drugs rather than using expensive, trial-and-error approaches in the laboratory.” The average cost of discovering a new drug and […]Read More